# A Study of MK0140 in Diabetic Patients With Macular Edema (0140-001)

> **NCT00692614** · PHASE2 · TERMINATED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 2 (actual)

## Conditions studied

- Macular Edema

## Interventions

- **DRUG:** triamcinolone acetonide

## Key facts

- **NCT ID:** NCT00692614
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-06
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2015-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00692614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00692614, "A Study of MK0140 in Diabetic Patients With Macular Edema (0140-001)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00692614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*